Norovirus

Infectious Disease

12 drugs in development·4 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(1)

Drug	Company
mrna-1405	Moderna, Inc. (MRNA)

Phase 2(3)

Drug	Company
bivalent norovirus vaccine candidate	Vaxart, Inc. (VXRT)
investigational oral vaccine candidate for covid-19	Vaxart, Inc. (VXRT)
seasonal influenza vaccine candidate	Vaxart, Inc. (VXRT)

Phase 1(3)

Phase 1/Phase 2(3)

Drug	Company
norovirus gi.1 norwalk virus inoculum	Vaxart, Inc. (VXRT)
vxa-g1.1-nn	Vaxart, Inc. (VXRT)
vxa-g2.4-ns	Vaxart, Inc. (VXRT)

Phase 2/Phase 3(1)

Drug	Company
hil-216	HilleVax, Inc. (HLVX)

Phase 4(1)

Drug	Company
mrna-1403	Moderna, Inc. (MRNA)

BioSniper tracks 12 drugs in development for Norovirus across 4 companies.

There are 1 clinical trial targeting Norovirus tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.